AVDL Logo

Avadel Pharmaceuticals plc (AVDL) 

NASDAQ
Market Cap
$746.8M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
169 of 950
Rank in Industry
7 of 57

Largest Insider Buys in Sector

AVDL Stock Price History Chart

AVDL Stock Performance

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Insider Activity of Avadel Pharmaceuticals plc

Over the last 12 months, insiders at Avadel Pharmaceuticals plc have bought $722,035 and sold $0 worth of Avadel Pharmaceuticals plc stock.

On average, over the past 5 years, insiders at Avadel Pharmaceuticals plc have bought $939,312 and sold $1.52M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Ende Eric J (director) — $470,436. Glass Geoffrey Michael (director) — $199,641. Divis Gregory J (Chief Executive Officer) — $99,707.

The last purchase of 30,000 shares for transaction amount of $235,218 was made by Ende Eric J (director) on 2025‑01‑13.

List of Insider Buy and Sell Transactions, Avadel Pharmaceuticals plc

2025-01-13Purchasedirector
30,000
0.0321%
$7.84$235,218+2.62%
2025-01-13Purchasedirector
10,000
0.011%
$8.04$80,450+2.62%
2024-12-13PurchaseChief Financial Officer
2,300
0.0024%
$10.44$24,019+1.16%
2024-12-11PurchaseChief Financial Officer
5,000
0.0052%
$10.49$52,433+1.84%
2024-12-10Purchasedirector
20,279
0.0208%
$9.84$199,641+5.05%
2024-12-09PurchaseChief Executive Officer
402
0.0004%
$9.82$3,948+3.45%
2024-12-06Purchasedirector
3,000
0.0031%
$10.19$30,568+4.45%
2024-12-06PurchaseChief Executive Officer
9,598
0.0098%
$9.98$95,759+4.45%
2024-01-16PurchaseChief Financial Officer
2,000
0.0021%
$14.50$29,000+1.45%
2023-12-28Saledirector
75,000
0.0802%
$14.53$1.09M+3.15%
2023-08-14PurchaseChief Financial Officer
2,000
0.0027%
$14.45$28,900+3.32%
2023-08-11Saledirector
28,975
0.0388%
$14.93$432,614-1.05%
2023-08-10PurchaseChief Executive Officer
10,000
0.0128%
$13.20$131,997+7.26%
2023-08-10Purchasedirector
14,000
0.0182%
$13.40$187,600+7.26%
2023-05-18Purchasedirector
13,000
0.0207%
$13.93$181,100+2.60%
2023-05-09Purchasedirector
2,500
0.0038%
$14.76$36,900-6.72%
2022-12-23Purchasedirector
2,000
0.0033%
$7.20$14,405+61.03%
2022-11-29PurchaseChief Financial Officer
5,000
0.008%
$7.80$39,000+36.61%
2022-11-22Purchasedirector
20,000
0.0314%
$7.80$156,050+32.02%
2022-06-01Purchase
45,000
0.068%
$2.14$96,300+191.25%

Insider Historical Profitability

21.84%
Ende Eric Jdirector
208900
0.2168%
$7.75100+59%
Thornton Peter J.director
104055
0.108%
$7.7530+78.3%
MCHUGH THOMAS SChief Financial Officer
87800
0.0911%
$7.7590+48.83%
Glass Geoffrey Michaeldirector
75904
0.0788%
$7.7590+72.31%
Palczuk Lindadirector
66400
0.0689%
$7.7560+51.17%
Divis Gregory JChief Executive Officer
10000
0.0104%
$7.7580+31.52%
Broadfin Healthcare Master Fund Ltd10 percent owner
4133464
4.2895%
$7.7502
Flynn James E10 percent owner
952265
0.9882%
$7.7501
STAPLETON CRAIG Rdirector
323413
0.3356%
$7.75121<0.0001%
ANDERSON MICHAEL SChief Executive Officer
248953
0.2584%
$7.75111<0.0001%
THOMPSON PHILLANDAS T.See Remarks
91000
0.0944%
$7.7530<0.0001%
McCamish Mark Anthonydirector
67025
0.0696%
$7.7522+28.91%
Hatten Sandra LSee Remarks
55765
0.0579%
$7.7543<0.0001%
KANAN MICHAEL FSee Remarks
29538
0.0307%
$7.7511<0.0001%
CERUTTI GUILLAUMEdirector
23440
0.0243%
$7.7501
FILDES FRANCISdirector
15000
0.0156%
$7.7501
GUSKY DAVID PController & CAO
4083
0.0042%
$7.7501

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Janus Henderson$218.18M13.4412.92M+16.09%+$30.24M0.11
RTW Investments, LP$148.61M9.158.8M+26.64%+$31.26M2.23
Polar Capital$114.07M7.036.75M+0.03%+$31,922.100.63
Vivo Capital$67.09M4.133.97M-3.04%-$2.1M5.84
Braidwell Lp$45.07M2.782.67MNew+$45.07M2.55
Wealth Effects Llc$38.24M2.362.26M-6.29%-$2.57M5.63
Adage Capital Partners Gp L L C$32.28M1.991.91M+749.33%+$28.48M0.06
Millennium Management LLC$30.61M1.891.81M+786.07%+$27.16M0.02
Citadel Advisors LLC$26.41M1.631.56M+155.04%+$16.06M0.02
Woodline Partners LP$25.34M1.561.5M-19%-$5.94M0.22
Brandes Investment Partners$24.7M1.521.46M-4.66%-$1.21M0.32
Tri Locum Partners Lp$20.09M1.241.19M+41.62%+$5.9M1.66
Tang Capital Management, LLC$17.69M1.091.05M-2.99%-$544,753.180.07
Samsara Biocapital Llc$16.34M1.01967,5270%+$02.55
Bioimpact Capital Llc$14.71M0.91871,149+31%+$3.48M2.38
Elequin Securities Llc$11.64M0.71686,606New+$11.64M0.45
Penn Capital Management Co Inc$11.64M0.71686,606New+$11.64M0.45
Morgan Stanley$11.24M0.69665,411-32.92%-$5.52M<0.01
Kennedy Capital Management Inc$11.03M0.68653,147+1.13%+$122,840.970.23
Modera Wealth Management$10.14M0.63600,449+0.34%+$34,742.730.17
Tupelo Capital Management LLC$10.13M0.62600,0000%+$00.25
Deutsche Bank$9.54M0.59565,000+28.41%+$2.11M<0.01
Altium Capital Management Lp$9.34M0.58553,057New+$9.34M1.1
Ally Bridge Group$9.24M0.57547,036+57.63%+$3.38M5.2
Renaissance Technologies$6.86M0.42406,006-35.05%-$3.7M0.01
New York State Common Retirement Fund$6.75M0.42399,551New+$6.75M0.01
Parkman Healthcare Partners Llc$6.55M0.4387,770New+$6.55M0.82
Goldman Sachs$6.32M0.39374,203-23.2%-$1.91M<0.01
Schonfeld Group$5.44M0.34322,000New+$5.44M0.03
Kairos Capital Management Lp$5.38M0.33318,240New+$5.38M2.57
Balyasny Asset Management Llc$5.23M0.32309,712-60.37%-$7.97M0.01
Ameriprise Financial$4.92M0.3291,274+0.75%+$36,482.40<0.01
Obermeyer Wood Investment Counsel LLLP$4.72M0.29279,494New+$4.72M0.28
Hudson Bay Capital Management LP$4.21M0.26249,160New+$4.21M0.03
Lord Abbett$3.26M0.2193,233New+$3.26M0.01
Cubist Systematic Strategies$2.85M0.18168,528+1,722.52%+$2.69M0.03
Schulhoff Co Inc$2.31M0.14137,000+42.71%+$692,490.001.06
Dorsey Wright Associates$2.16M0.13127,640New+$2.16M0.57
Jump Financial Llc$2.13M0.13126,000+532.78%+$1.79M0.02
Royal Bank of Canada$2.07M0.13122,565+3,328.39%+$2.01M<0.0001
Russell Investments Group Ltd$1.94M0.12115,041New+$1.94M<0.01
CETERA INVESTMENT ADVISERS LLC$1.93M0.12113,978New+$1.93M<0.01
MAI Capital Management, LLC$1.89M0.12111,605+4.23%+$76,427.230.02
Geode Capital Management$1.76M0.11104,227+12.58%+$196,667.16<0.0001
Mml Investors Services Llc$1.72M0.11101,931+36.12%+$456,976.780.01
Cetera Advisors LLC$1.55M0.192,017+8.91%+$127,198.580.01
Investors Asset Management Of Georgia Inc Ga Adv$1.48M0.0987,375-17.94%-$322,599.050.71
Lion Point Capital LP$1.39M0.0982,500+3.13%+$42,225.002.7
D. E. Shaw & Co.$1.39M0.0982,109-58.23%-$1.93M<0.01
BlackRock$1.29M0.0876,442-6.24%-$85,970.14<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.